Loading Events

« All Events

  • This event has passed.

Cell & Gene Therapy 2018

October 10 - October 11


CLICK HERE TO FIND OUT MORE

Cell & Gene Therapy 2018

10-11 October 2018, London, UK

ADVERTISEMENT

SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th
and 11th October 2018, with an interactive pre-conference workshop on the 9th October.

Cell and gene therapeutics have revolutionized modern medicine and mark a new generation in
biomedical and agricultural sciences. The latest developments in cell and gene therapies and
specifically in gene editing, technologies present unlimited research opportunities ranging from
novel therapeutic tools to a potential revolution in the field of drug discovery.

This year’s event will be led by scientists and clinicians researching, developing and testing new
treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell
manipulation and DNA repair techniques. The conference will cover all aspects of the subject,
including biomedical science principles, the molecular basis of disease, current and developing
technologies and clinical applications.

The conference will be inviting speakers from global pharmaceutical organizations, leading biotech
companies and internationally renowned academic institutions Expect over 16 presentations and
case studies focused on the key aspects of GMP, bioprocessing, regulatory frameworks and new
therapeutic developments in the field of cell and gene.

Hear from our expert speaker panel, bringing you interesting case studies and detailed presentations
on new and industry relevant topics, including:
– Cell Therapy Research
– Manufacturing Innovation
– Global Medical Affairs
– Regulatory Updates
– GMP and Quality Control
– Cell and Tissue Therapies (CAR-T therapies, stem cells, cord blood, preclinical and clinical
developments)
– Regenerative Medicine
– Advanced Therapy Production
– Gene Therapy Development
– Clinical Platform Development
– Manufacturing
– R&D of Cell and Gene Therapies

CHAIR FOR 2018:
– Pamela Tranter, Head Of Translational Research Group, UCL

KEY SPEAKERS INCLUDE:

Event Listing – Cell & Gene Therapy
– Janet Glassford, Senior Quality Assessor (Biologicals), MHRA
– Giuseppe Ronzitti, Cell and Gene Therapy Specialist, Genethon
– Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
– Shailesh Gupta, Senior Scientist, AstraZeneca
– Peggy Sotiropoulou, R&D Manager, Research and Development, Celyad
– Julie Kerby, Head of Manufacturing Development, Cell and Gene Therapy Catapult
– Lior Raviv, Vice President, Development, Pluristem
– Diego Aridgo, R&D Rare Disease Unit Head, Chiesi
– Mehdi Gasmi, Chief Science and Technology Officer, Adverum Biotech
– Emanuela Cuomo, Associate Director, Discovery Sciences, Cellular Biology Team,
AstraZeneca
– Yen Choo, Founder and Executive Chairman, Plasticell
– Ian McKay, Innovation Lead Advanced Therapies, Innovate UK

2018 FEATURED HIGHLIGHTS:
– Discuss the challenges of accessing patients with commercial ATMPs
– Understand the advantages of a risk-based approach to cell and gene therapy
manufacturing
– Hear the MHRA’s perspective of UK and EU regulatory affairs regarding ATMPs
– Explore the unique applications of the CRISPR/Cas9 system for drug development at
AstraZeneca
– Gain insight into GMP Manufacture of plasmid DNA at the NHSBT
View the full agenda online: www.cellandgeneconference.com/labt

EARLY-BIRD RATES:
– REGISTER BY 31ST MAY AND SAVE £400
– REGISTER BY 29TH JUNE AND SAVE £300
– REGISTER BY 31ST AUGUST AND SAVE £200

CLICK HERE TO FIND OUT MORE

Organizer

SMi Group
Phone:
+44 (0) 207 827 6012
Email:
kwilliams@smi-online.co.uk
Website:
https://www.smi-online.co.uk/

Venue

Copthorne Tara Hotel London Kensington
London, United Kingdom + Google Map

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.